Uncategorized | New York Transcatheter Valves Symposium

WELCOME AND INTRO
Annapoorna S. Kini, MD; Sahil Khera, MD; Gilbert H.L. Tang, MD; Stamatios Lerakis, MD

0:07:43

Top Ten Advances in Transcatheter Valve Therapy 2023
Samin K. Sharma, MD

0:31:41

SPOTLIGHT Lecture: Where Will TAVR be in 2030? Who Will We be Treating?
Eberhard Grube, MD

0:12:16

TAVR of Pure Aortic Regurgitation; Current Status
Raj Makkar, MD

0:12:19

Minimalistic and Ambulatory TAVR Program
Samir Kapadia, MD

0:08:32

Latest Adjunctive Technologies in TAVR:Cerebral Embolic Protection, Leaflet Mods
Alexandre Abizaid

0:12:47

Optimizing First TAVR to Confer Optimal Durability? Pre vs. Post Dilate? Fracture?
Kendra J. Grubb, MD

0:09:42

Redo-TAVR: An Emerging Epidemic? The Knowns and Unknowns
Vinayak N. Bapat, MD

0:11:16

Panel Discussion
Audience Q&A

0:05:41

LIVE CASE 1 & 2 | SAPIEN TAV-IN-TAV and EVOLUT™ FX TAVR

0:56:24

SPOTLIGHT Lecture: Where Will Transcatheter Mitral Interventions be in 2030?
Anita Asgar, MD

0:11:04

Expanding Mitral TEER Treatable Anatomies: What Can Our Current Devices Do?
Edwin C. Ho, MD

0:08:07

Next Rounds of Transcatheter Mitral Trials: Are RCTs Between TEER and TMVR Necessary?
Gregg W Stone, MD

0:14:11

TMVR in MAC: 10 Years of Experience: Lessons Learned and Future Directions
Vinayak N. Bapat, MD

0:11:07

Panel Discussion
Audience Q&A

0:08:57

LIVE CASE #3 and #4

0:55:03

LIVE CASE #5

0:39:32

SPOTLIGHT Lecture: Advances in Imaging for Tricuspid Valve Intervention: Lessons Learned, Future Direction
Rebecca T Hahn, MD

0:14:39

How to Select Patients for Tricuspid TEER: The Green, Yellow and Red Patients
Anita Asgar, MD

0:10:43

How Do We Interpret Tricuspid TEER Trials and Registries
Paul Sorajja, MD

0:13:05

DEBATE: Replacement to Prevail in Transcatheter Tricuspid Intervention Pro / Con

0:15:26

LIVE CASE #6

0:21:32

LIVE CASE #7

0:29:21

Latest Advances in LAAO
Gagan Singh, MD

0:13:09

Case Presentations by Structural Heart Fellows

0:41:54

CONCLUDING REMARKS
Annapoorna S. Kini, MD; Sahil Khera, MD; Stamatios Lerakis, MD; Gilbert H. L. Tang, MD

0:05:22

NYTV 2022 Opening Video

0:02:15

Welcome and Introduction

0:04:12

Top Ten Advances in Transcatheter Valve Therapy 2022

0:36:30

Latest Update on Valvular Heart Disease: Strides Made, Looking to the Future

0:15:39

Latest Update on Heart Valve Surgery

0:17:30

Latest Update on Transcatheter Valve Therapies

0:09:22

Open Discussion with the Legends

0:07:18

Live Case 1 – VALVE-IN-VALVE

0:25:12

Live Case 2 – TAV-IN-TAV

0:17:05

Valve in Valve TAVR

0:9:27

TAVR in Small Annulus

0:13:32

TAVR and CAD

0:6:14

Neuroprotection in TAVR: A Post PROTECT TAVR Evaluation

0:13:28

TAVR in Asymptomatic or Moderate AS

0:9:14

TAVR Pharmacology

0:17:01

Q&A with Live Audience

0:16:57

Live Case 4 – FUNCTIONAL MR TEER

0:53:24

KEYNOTE LECTURE: Advances in Imaging in Mitral and Tricuspid Valve Intervention: Lessons Learned, Future Direction

0:18:58

Mitral Valve Intervention Post COAPT Era

0:15:58

Tricuspid Valve Interventions: The Future of Transcatheter Valves in this Arena

0:10:22

FLASH DEBATE | Endpoints for Mitral TEER Trials Are Too Soft – Pro

0:12:07

FLASH DEBATE | Endpoints for Mitral TEER Trials Are Too Soft – Con

0:11:42

Live Case 5 – TMVR

0:32:49

Live Case 6 – VALVE-IN-VALVE TAVR

0:11:41

Case Presentation 1

0:11:47

Case Presentation 2

0:9:21

Case Presentation 3

0:11:57

Case Presentation 4

0:12:16

Concluding Remarks

0:02:25

Welcome and Introduction

0:05:22

Top Ten Advances in Transcatheter Valve Therapy 2021

0:33:59

The History of TAVR

0:36:38

TAVR: A Global Perspective, Where Are We Today?

0:17:50

Where Are We Heading?

0:14:37

Live Case 1 – Valve-in-Valve TAVR

0:24:27

Small Annulus – Update on the SMART Trial

0:13:41

Neuro Protection in TAVR: What’s New

0:09:39

Pharmacology in TAVR: State of the Art

0:10:40

TAVR + CAD: Rationale & Update on COMPLETE TAVR Trial

0:12:35

TAVR for Aortic Regurgitation

0:10:29

Valve-in-Valve: Clinical Data and the ViV App

0:15:51

Live Case 2 – Small Annulus TAVR

0:21:00

Live Case 3 – Functional MR TEER

1:12:33

KEYNOTE LECTURE: Mitral – Next Generation Devices

0:23:01

Mitral Clip: The Promise for the Future: Ongoing Trials & More

0:22:46

Tricuspid Valve: Front & Center

0:11:23

Imaging for Guidance in Tricuspid & Mitral Interventions: What’s New; Role of ICE & 4D

0:17:27

Live Case 4 – Bicuspid Valve TAVR

0:12:04

Case Presentation 1

0:11:07

Case Presentation 2

0:09:22

Case Presentation 3

0:14:30

Case Presentation 4

0:14:30

Concluding Remarks

0:02:37

Planning and Results of Transcatheter Tricuspid Valve Therapy

0:18:35

Tricuspid Valve Disease: Pathophysiology and Evolving Therapies

0:12:55

Update on Mitral Clip: COAPT and More

0:16:13

Next Generation Mitral Devices for Repair/Replacement

0:16:05

Coronary Access Post TAVR: TAVRCathAID

0:11:46

Failed TAVR: Results from Surgical Explants

0:11:34

TAVR and CAD: Rationale and Design of the COMPLETE TAVR Trial

0:11:36

Update on Pharmacology Post TAVR: Future Directions

0:17:42

Neuro-Protection in TAVR: Is it Effective?

0:13:46

TAVR in Small Annulus: The SMART Trial

0:12:02

TAVR in Bicuspid Valve

0:13:46

Current Update on Next Generation TAVR Valves

0:15:17

Adapting to Change in Structural Heart Disease Training

0:10:34

Valvular Heart Disease in the COVID Era: The Path Forward

0:26:57

Top Ten Advances in Transcatheter Valve Therapy 2020

0:31:11

Alcohol Septal Ablation for HOCM: Case Selection

0:14:59

TPVR Devices: Update

0:10:12

Trials of Tricuspid Valve Technology in 2020: Where are we Now?

0:14:16

TMVR Technologies vs. Surgical Therapies for Mitral Regurgitation

0:10:22

Novel TMVR Technologies: View of the Future

0:13:13

Current and Future Trials of Transcatheter Mitral Valve Replacement

0:12:05

Future of MitraClip Post COAPT Trial

0:10:54

Key Points in Imaging for Transcatheter Valve Therapy

0:11:05

Minimalistic TAVR: Early Discharge and Pacing Algorithm

0:10:50

Alternate Vascular Access of TAVR

0:8:36

Managing Complications of TAVR

0:10:53

Adjunctive Pharmacotherapy During TAVR: Update

0:12:49

TAVR in Bicuspid AS: Standard of Care or Do We Need a Randomized Trial?

0:12:28

New Next Generation TAVR Technology in 2020+

0:11:16

Transcatheter Valve Therapies in Heart Failure: New Perspective in 2020

0:21:31

Transcatheter Valve Therapies in 2020: A Surgeon’s Perspective

0:21:21

Valvular Heart Disease in 2020: State of the Art

0:18:54

Top Ten Advances in Transcatheter Valve Therapy in 2019

0:31:51